Plasma metabolomic profiling of patients with diabetes-associated cognitive decline

scientific article published on 14 May 2015

Plasma metabolomic profiling of patients with diabetes-associated cognitive decline is …
instance of (P31):
scholarly articleQ13442814

External links are
P819ADS bibcode2015PLoSO..1026952Z
P356DOI10.1371/JOURNAL.PONE.0126952
P8608Fatcat IDrelease_bkr3qyucy5fwhjat4avq3gnl3a
P932PMC publication ID4431856
P698PubMed publication ID25974350
P5875ResearchGate publication ID276358810

P2093author name stringLin Zhang
Meng Li
Ying Liu
Xiaoguang Lu
Hua Sui
Libin Zhan
Lina Liang
Benli Su
Zhengnan Gao
Yuzhong Li
Qigui Liu
Benhui Wu
P2860cites workAssociation of cognitive function with serum uric acid level among Chinese nonagenarians and centenarians.Q51857538
Diabetes mellitus and the risk of dementia: The Rotterdam Study.Q53231897
UHPLC/Q-TOF MS-based plasma metabolic profiling analysis of the bleeding mechanism in a rat model of yeast and ethanol-induced blood heat and hemorrhage syndrome.Q54326878
Serum uric acid and cognitive function in community-dwelling older adultsQ79482269
Pharmacometabonomic phenotyping reveals different responses to xenobiotic intervention in ratsQ79801989
Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studiesQ83528586
Determination of polyamines in human plasma by high-performance liquid chromatography coupled with Q-TOF mass spectrometryQ87390045
Translational biomarker discovery in clinical metabolomics: an introductory tutorialQ24598642
Global prevalence of diabetes: estimates for the year 2000 and projections for 2030Q27860575
Principles of bioactive lipid signalling: lessons from sphingolipidsQ28265743
Bile acids induce energy expenditure by promoting intracellular thyroid hormone activationQ28290455
Effect of streptozotocin-induced diabetes on oxidative energy metabolism in rat kidney mitochondria. A comparative study of early and late effectsQ28564281
Metabolite profiles and the risk of developing diabetesQ29615359
XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identificationQ29616057
Integration of metabolomics and transcriptomics data to aid biomarker discovery in type 2 diabetesQ33612373
Metabolomic Analysis Reveals Amino Acid Responses to an Oral Glucose Tolerance Test in Women with Prior History of Gestational Diabetes MellitusQ33738286
Sugar, uric acid, and the etiology of diabetes and obesity.Q34038315
Identification of altered metabolic pathways in plasma and CSF in mild cognitive impairment and Alzheimer's disease using metabolomics.Q34735142
Sphingolipid metabolites in inflammatory diseaseQ35061720
Risk of dementia in diabetes mellitus: a systematic reviewQ36345254
Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approachQ36560652
Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolismQ36861002
Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetesQ37019642
Risk of incident Alzheimer's disease in diabetic patients: a systematic review of prospective trialsQ37455807
Impaired glycemia increases disease progression in mild cognitive impairmentQ37489320
Association of type 2 diabetes with brain atrophy and cognitive impairmentQ37665715
Sphingolipids: agents provocateurs in the pathogenesis of insulin resistanceQ37862117
Metabolomic biomarkers of impaired glucose tolerance and type 2 diabetes mellitus with a potential for risk stratification in women with polycystic ovary syndrome.Q37964067
Diabetes and cognitive dysfunctionQ38017477
Sphingolipids: critical players in Alzheimer's diseaseQ38029867
An update on type 2 diabetes, vascular dementia and Alzheimer's diseaseQ38033909
Pancreatic carcinoma, pancreatitis, and healthy controls: metabolite models in a three-class diagnostic dilemmaQ40634575
A new metabolomic signature in type-2 diabetes mellitus and its pathophysiologyQ41877592
Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stressQ42829265
Insulin resistance is associated with the pathology of Alzheimer disease: the Hisayama studyQ42925710
Oxidative stress with an activation of the renin-angiotensin system in human vascular endothelial cells as a novel mechanism of uric acid-induced endothelial dysfunctionQ43058797
Effects of streptozotocin-induced diabetes and elevation of plasma FFA on ceramide metabolism in rat skeletal muscleQ43276753
Effect of mitiglinide on Streptozotocin-induced experimental type 2 diabetic rats: a urinary metabonomics study based on ultra-performance liquid chromatography-tandem mass spectrometryQ43277645
Metabonomics research of diabetic nephropathy and type 2 diabetes mellitus based on UPLC-oaTOF-MS systemQ43283024
Metabonomic variations in the drug-treated type 2 diabetes mellitus patients and healthy volunteers.Q43284301
Xanthine oxidase and lens oxidative stress markers in diabetic and senile cataract patientsQ44444558
Oxidative balance, homocysteine, and uric acid levels in older patients with Late Onset Alzheimer's Disease or Vascular Dementia.Q45721593
High temperature-ultra performance liquid chromatography-mass spectrometry for the metabonomic analysis of Zucker rat urineQ45736396
Metabolic links between diabetes and Alzheimer's disease.Q46032053
Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin systemQ46809905
Metabonomic analysis of the therapeutic effect of Zhibai Dihuang Pill in treatment of streptozotocin-induced diabetic nephropathyQ47197680
Systems biology: MetabonomicsQ47647280
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P4510describes a project that usesCytoscapeQ3699942
P433issue5
P407language of work or nameEnglishQ1860
P921main subjectmetabolomic profilingQ118125815
P304page(s)e0126952
P577publication date2015-05-14
P1433published inPLOS OneQ564954
P1476titlePlasma metabolomic profiling of patients with diabetes-associated cognitive decline
P478volume10

Reverse relations

cites work (P2860)
Q50099673Dysregulation of Δ4-3-oxosteroid 5β-reductase in diabetic patients: Implications and mechanisms.
Q92095136Identification of disordered metabolic networks in postpartum dairy cows with left displacement of the abomasum through integrated metabolomics and pathway analyses
Q36278521Impact of a cafeteria diet and daily physical training on the rat serum metabolome.
Q55256698Metabolomics and pathway analyses to characterize metabolic alterations in pregnant dairy cows on D 17 and D 45 after AI.
Q96685717Parallel validation of a green-solvent extraction method and quantitative estimation of multi-mycotoxins in staple cereals using LC-MS/MS

Search more.